Listing 14.09 in 2026: How Social Security Decides Inflammatory Arthritis Claims Under 14.09A, 14.09B, 14.09C, and 14.09D, Why Ankylosing Spondylitis and Psoriatic Arthritis Have Their Own Subpart, and the Documentation That Decides Step 3

By Anthony Albert, Benefits Research Director · Published June 16, 2026 · 14 min read

Inflammatory arthritis is one of the most common impairments at Social Security and one of the most poorly documented. People file claims with a rheumatoid arthritis diagnosis, a few prescriptions for biologics, and a couple of office notes mentioning joint pain. That file goes straight to denial because Listing 14.09 is not built around the diagnosis. It is built around what the disease has done to your body and your function.

If you want to win on inflammatory arthritis, you have to know which of the four 14.09 subparts your case fits into, what evidence each one demands, and where the medical record needs work before the hearing. This is the 2026 walkthrough.

What inflammatory arthritis covers under SSA rules

Listing 14.09 sits inside section 14.00 of the Blue Book, the immune system disorders. SSA uses it for any inflammatory arthritis, including:

• Rheumatoid arthritis (RA)
• Psoriatic arthritis (PsA)
• Ankylosing spondylitis (AS)
• Reactive arthritis (formerly Reiter's syndrome)
• Inflammatory bowel disease-associated arthritis (Crohn's, ulcerative colitis)
• Whipple's disease
• Behcet's disease
• Juvenile idiopathic arthritis that persists into adulthood

Osteoarthritis and gout do not fit here. Osteoarthritis gets evaluated under Listing 1.18 (abnormality of major joint). Gout is technically a crystal arthropathy and falls under 14.09 only when chronic, erosive, and tophaceous.

Section 14.00D6 of the Blue Book contains the detailed rules. It splits inflammatory arthritis into two clinical patterns. The first is peripheral, meaning the disease attacks the joints of the arms and legs. The second is axial, meaning the disease attacks the spine and sacroiliac joints. The four subparts of 14.09 map to those two patterns.

14.09A: persistent inflammation or deformity in peripheral joints

14.09A is the easiest path on paper and the hardest in practice. It requires persistent inflammation or persistent deformity of:

1. One or more major peripheral weight-bearing joints (hip, knee, ankle) resulting in the inability to ambulate effectively, as defined in 1.00B2b, or
2. One or more major peripheral joints in each upper extremity (shoulder, elbow, wrist-hand) resulting in the inability to perform fine and gross movements effectively.

The traps are in the definitions. "Inability to ambulate effectively" under 1.00B2b means an extreme limitation of the ability to walk, generally requiring the use of a hand-held assistive device that limits the functioning of both upper extremities. A single cane is not enough. The claimant has to need bilateral canes, crutches, a walker, or a wheeled mobility device that uses both hands.

"Inability to perform fine and gross movements effectively" requires an extreme loss of function of both upper extremities. The claimant cannot prepare a simple meal, bathe, take care of personal hygiene, sort and handle papers or files, or carry out work activities at a reasonable pace.

That bar is high. Most inflammatory arthritis claimants do not meet 14.09A even with severe disease, because they can still walk with a single cane or use one hand functionally. 14.09A is reserved for the most advanced cases.

If your case fits 14.09A, the documentation has to include:

• Rheumatologist notes confirming the diagnosis and disease activity
• Imaging (X-ray, MRI, or ultrasound) showing joint erosion, deformity, or destruction
• Physical therapy or occupational therapy evaluations of ambulation or fine/gross motor function
• Assistive device prescriptions or medical source statements documenting the need
• Twelve-month durational projection

14.09B: arthritis with constitutional symptoms and organ involvement

14.09B is the subpart most rheumatoid arthritis cases actually fit. It requires inflammation or deformity in one or more major peripheral joints with both of these:

1. Involvement of two or more organs or body systems with one of them involved to at least a moderate level of severity, and
2. At least two of the four constitutional symptoms or signs: severe fatigue, fever, malaise, or involuntary weight loss.

The phrase "organs or body systems" is broader than most claimants realize. RA can attack the lungs (interstitial lung disease, pleuritis), the eyes (scleritis, episcleritis, uveitis), the heart (pericarditis, valvular disease), the skin (rheumatoid nodules, vasculitis), the kidneys (amyloidosis, glomerulonephritis), the peripheral nerves (mononeuritis multiplex), and the blood (Felty's syndrome, anemia of chronic disease). Each of these counts as a separate body system.

For 14.09B you need rheumatology notes documenting the joint disease plus specialty notes documenting the organ involvement. A pulmonologist's note diagnosing RA-related interstitial lung disease is gold. An ophthalmologist's note for scleritis is gold. A cardiologist's echo showing pericarditis is gold.

"Moderate level of severity" is not defined sharply in the Blue Book. SSA reads it through 14.00C5, which describes moderate severity as "significant" impairment requiring substantial intervention. In practice that means treatment beyond watch-and-wait. Steroid courses for pulmonary involvement, immunosuppressive infusions for vasculitis, surgical interventions for refractory ocular disease all clear the threshold.

Constitutional symptoms require documentation, not just patient report. Severe fatigue should be quantified by treating notes (cannot complete usual tasks, sleeps 12+ hours daily, requires daytime rest). Fever needs charted temperatures or ER documentation. Involuntary weight loss needs serial weights in the chart, ideally showing 10 percent or more loss from baseline.

14.09C: ankylosing spondylitis and other spondyloarthropathies

14.09C is the only subpart that targets axial disease. It applies to ankylosing spondylitis, axial psoriatic arthritis, reactive arthritis, IBD-related axial disease, and other spondyloarthropathies that fix the spine.

The two paths under 14.09C are:

1. 14.09C1: Ankylosis (fixation) of the dorsolumbar or cervical spine documented by appropriate medically acceptable imaging and measured on physical examination at 45 degrees or more of flexion from the vertical position (zero degrees).
2. 14.09C2: Ankylosis of the dorsolumbar or cervical spine documented by imaging and measured on physical examination at 30 degrees or more of flexion (but less than 45 degrees), and involvement of two or more organs/body systems with one involved to at least a moderate level of severity.

The flexion measurement is the central evidence in any AS case. Measurement happens with the patient standing as upright as possible against a wall, with the practitioner measuring the angle between the spine and the vertical wall using a goniometer or inclinometer. The Schober test and the occiput-to-wall distance are supplementary measurements that build the imaging-plus-exam case but do not by themselves satisfy 14.09C.

14.09C1 is one of the cleanest meet-or-equal paths in the Blue Book because it does not require constitutional symptoms or organ involvement. If your spine is fixed at 45 degrees of flexion or more, you qualify on the spine evidence alone. The Blue Book specifically states that this level of fixation impairs your ability to see in front of you, above you, and to the side, which SSA treats as a listing-level physical limitation by itself.

For 14.09C2, the 30-to-44 degree range, you need the same axial fixation plus the organ involvement track from 14.09B. Common AS extra-articular features that count include uveitis or iritis (eyes), aortic insufficiency or conduction blocks (heart), apical pulmonary fibrosis (lungs), IgA nephropathy (kidneys), and IBD (digestive).

14.09D: repeated manifestations with marked functional limitation

14.09D is the catch-all for active inflammatory arthritis that does not fit the joint, organ, or spine paths. It requires:

1. Repeated manifestations of inflammatory arthritis (joint inflammation, deformity, fevers, fatigue, malaise, or weight loss recurring or persisting),
2. At least two of the four constitutional symptoms (severe fatigue, fever, malaise, involuntary weight loss), and
3. One of these at the "marked" level:
   • Limitation of activities of daily living
   • Limitation in maintaining social functioning
   • Limitation in completing tasks in a timely manner due to deficiencies in concentration, persistence, or pace

The functional terminology mirrors the old paragraph B mental criteria. "Marked" means seriously interfering with the ability to function independently, appropriately, effectively, and on a sustained basis.

14.09D is where psoriatic arthritis cases often land. PsA can produce severe peripheral disease, dactylitis, enthesitis, fatigue, and skin involvement without the clean axial fixation of AS or the textbook organ involvement of RA. A PsA claimant who has frequent flares, documented severe fatigue, involuntary weight loss, and a treating rheumatologist's statement that the patient cannot reliably sustain daily activities can meet 14.09D.

The functional limitation has to be documented by treating sources. Self-report alone does not carry the day. The claimant's spouse, employer, or therapist can supplement, but the medical file needs a clear opinion from a treating physician or psychologist about the functional severity. SSR 16-3p on subjective symptom evaluation controls how the ALJ weighs the claimant's testimony against the medical record.

Constitutional symptoms: what they mean and how to prove them

Section 14.00C2 defines the constitutional symptoms. Each one has a specific meaning at SSA.

SSA requires two of these four for both 14.09B and 14.09D. The two do not have to be present simultaneously. They have to be documented across the relevant period.

How treatment evidence factors in

Treatment history is not a separate criterion under 14.09, but it shapes every adjudication. ALJs look at three things:

1. Aggressiveness of treatment. Methotrexate alone is one tier. Methotrexate plus a biologic (TNF inhibitor, JAK inhibitor, IL-6 blocker, IL-17 blocker, T-cell costimulation modulator) is more serious. Triple therapy with multiple advanced biologics signals severe disease.
2. Response to treatment. Active disease that persists despite multiple biologic trials is the strongest evidence of listing-level severity. A claimant who has tried and failed adalimumab, etanercept, infliximab, tocilizumab, and rituximab over five years has a different file than a claimant on first-line methotrexate.
3. Documented side effects or access barriers. Biologics cost roughly $30,000 to $80,000 per year at list. Even with insurance, copay assistance gaps and step therapy delays interrupt treatment. POMS DI 24515.012 lets adjudicators credit treatment gaps tied to cost.

If your rheumatologist will sign a treatment failure summary listing every drug, the duration, the response, and the reason for discontinuation, that document carries weight at every level of adjudication.

The RFC fight when listings fail

Most inflammatory arthritis claims do not meet a listing. They win at Steps 4 or 5 on residual functional capacity. The RFC factors that decide arthritis cases are:

• Standing and walking tolerance (often limited to 2 to 4 hours in an 8-hour day)
• Sitting tolerance (active disease often limits to 4 to 6 hours)
• Lifting and carrying (often limited to 10 to 20 pounds occasionally)
• Reaching, handling, and fingering (RA and PsA cases often have severe restrictions here)
• Off-task time and absences (severe fatigue, infusion days, flare days)

The combination of sedentary exertional limits plus restricted handling and fingering can grid out a claimant aged 50 or older. The grid rules at 20 CFR 404 Subpart P Appendix 2 are friendly to older claimants with manipulative limitations because most sedentary unskilled work requires intact fine motor control.

For arthritis claimants under 50, the path is usually proving that the combined limitations erode the unskilled sedentary base. SSR 96-9p describes that erosion. Frequent loss of upper extremity function (handling/fingering limited to occasional) combined with the need to alternate sit/stand at will often erodes the base completely.

The five-step worked example

How to apply this listing to your case

1. Identify the subpart. Peripheral severe? 14.09A. Peripheral with organ involvement and constitutional symptoms? 14.09B. Axial fixation? 14.09C. Repeated manifestations with functional limitation? 14.09D.
2. Get current rheumatology notes documenting disease activity, treatment history, and response.
3. Pull specialty notes for every organ system involved.
4. For axial cases, get a goniometer or inclinometer flexion measurement in the rheumatology record. The Schober and occiput-to-wall measurements support the case but do not substitute for the angle.
5. Document constitutional symptoms with EMR weight trends, PROMIS fatigue scores, and treating notes.
6. For 14.09D cases, get a treating physician statement on functional limitation that uses the SSA "marked" terminology.
7. Build a complete medication failure log.

Bottom line

Listing 14.09 is winnable but only on a complete file. The four subparts are not redundant. They cover four different ways inflammatory arthritis can become disabling, and your medical evidence has to match one of them. The cases that win at Step 3 are the cases where the rheumatologist, the specialist for each affected organ system, and the treating physician all document the same story.

If you have inflammatory arthritis and you are filing or appealing, See If You Qualify and we will audit your file against the 14.09 criteria before SSA does.

Related reading

• Medical equivalence under 20 CFR 404.1526
• Listing 1.20 amputation criteria
• Listings 1.15 and 1.16 spinal disorders
• SSR 16-3p subjective symptom evaluation
• Disability benefits for lupus (Listing 14.02)

Frequently asked questions